Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Gossamer Bio has raised $212.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2023.
Gossamer Bio's investors include ARCH Venture Partners, Hillhouse Investment, Samsara BioCapital, New Enterprise Associates, Polaris Partners.
Gossamer Bio is headquartered in San Diego, United States.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Gossamer Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gossamer Bio — Funding & Investors." VCBacked, July 20, 2023, https://www.vcbacked.co/company/gossamer-bio. Accessed July 19, 2026.
VCBacked. (2023). Gossamer Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gossamer-bio
{{cite web |title=Gossamer Bio — Funding & Investors |url=https://www.vcbacked.co/company/gossamer-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated